SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
| PenicillAMINE | 250 mg | Capsule, hard · Oral use | 100 Bottle | SAR 336.95 | Generic · Prescription | Navinta LLC | Valid |
| ARTAMIN 150 MG CAPS | 150 mg | Capsule · Oral use | 50 Blister | SAR 61.85 | NCE · Prescription | SANDOZ | Withdrawn by MAH · Not Marketed |
| ARTAMIN 250 MG CAPS | 250 mg | Capsule · Oral use | 50 Blister | SAR 74.45 | NCE · Prescription | SANDOZ | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
| CUPRIMINE | 250MG | capsule · oral | VALEANT PHARMS INTL | Prescription | 4 Dec 1970 |
| DEPEN | 250MG | tablet · oral | MYLAN SPECIALITY LP | Prescription | 8 Nov 1978 |
| PENICILLAMINE | 250MG | capsule · oral | WATSON LABS INC | Prescription | 24 Jun 2019 |
| PENICILLAMINE | 250MG | tablet · oral | PH HEALTH | Prescription | 23 Dec 2019 |
| PENICILLAMINE | 250MG | capsule · oral | PH HEALTH | Prescription | 23 Dec 2019 |
| PENICILLAMINE | 250MG | capsule · oral | DR REDDYS | Prescription | 4 Aug 2020 |
| PENICILLAMINE | 250MG | tablet · oral | LUPIN | Prescription | 30 Nov 2020 |
| PENICILLAMINE | 250MG | capsule · oral | GRANULES | Prescription | 2 Dec 2020 |
| PENICILLAMINE | 250MG | capsule · oral | INVAGEN PHARMS | Prescription | 19 Aug 2021 |
| PENICILLAMINE | 250MG | capsule · oral | BRECKENRIDGE | Prescription | 23 Aug 2021 |
| PENICILLAMINE | 250MG | capsule · oral | NAVINTA LLC | Prescription | 8 Oct 2021 |
| CUPRIMINE | 125MG | capsule · oral | VALEANT PHARMS INTL | Discontinued | 4 Dec 1970 |
| LUXZYLA | 250MG | capsule · oral | ANI PHARMS | Discontinued | 7 May 2019 |
| PENICILLAMINE | 250MG | tablet · oral | TEVA PHARMS USA | Discontinued | 13 Feb 2020 |
| PENICILLAMINE | 250MG | capsule · oral | APOTEX | Discontinued | 28 Apr 2020 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
| CUPRIMINE | 00016055 | 250 MG | CAPSULE · ORAL | BAUSCH HEALTH, CANADA INC. |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
| NHS Drug Tariff | Penicillamine 125mg tablets | £93.11 | 56 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Penicillamine 250mg tablets | £140.00 | 56 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 4.2. Antidotes and other substances used in poisonings > Specific · core
Harmful effects of or exposure to noxious substances, chiefly nonmedicinal as to source, not elsewhere classified
Oral > Solid: 250 mg - 29.2. Disease-modifying anti-rheumatic drugs (DMARDs) · complementary
Rheumatoid arthritis, serology unspecified
Oral > Solid: 250 mg
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.